Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2019 5
2020 3
2021 3
2022 3
2023 5
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

18 results

Results by year

Filters applied: . Clear all
Page 1
Patient-tailored adoptive immunotherapy with EBV-specific T cells from related and unrelated donors.
Bonifacius A, Lamottke B, Tischer-Zimmermann S, Schultze-Florey R, Goudeva L, Heuft HG, Arseniev L, Beier R, Beutel G, Cario G, Fröhlich B, Greil J, Hansmann L, Hasenkamp J, Höfs M, Hundsdoerfer P, Jost E, Kafa K, Kriege O, Kröger N, Mathas S, Meisel R, Nathrath M, Putkonen M, Ravens S, Reinhardt HC, Sala E, Sauer MG, Schmitt C, Schroers R, Steckel NK, Trappe RU, Verbeek M, Wolff D, Blasczyk R, Eiz-Vesper B, Maecker-Kolhoff B. Bonifacius A, et al. Among authors: tischer zimmermann s. J Clin Invest. 2023 Jun 15;133(12):e163548. doi: 10.1172/JCI163548. J Clin Invest. 2023. PMID: 37159273 Free PMC article.
Rapid and sustained T cell-based immunotherapy against invasive fungal disease via a combined two step procedure.
Tischer-Zimmermann S, Salzer E, Bitencourt T, Frank N, Hoffmann-Freimüller C, Stemberger J, Maecker-Kolhoff B, Blasczyk R, Witt V, Fritsch G, Paster W, Lion T, Eiz-Vesper B, Geyeregger R. Tischer-Zimmermann S, et al. Front Immunol. 2023 Apr 5;14:988947. doi: 10.3389/fimmu.2023.988947. eCollection 2023. Front Immunol. 2023. PMID: 37090716 Free PMC article.
Long-Lasting Immunity Against SARS-CoV-2: Dream or Reality?
Gussarow D, Bonifacius A, Cossmann A, Stankov MV, Mausberg P, Tischer-Zimmermann S, Gödecke N, Kalinke U, Behrens GMN, Blasczyk R, Eiz-Vesper B. Gussarow D, et al. Among authors: tischer zimmermann s. Front Med (Lausanne). 2021 Nov 25;8:770381. doi: 10.3389/fmed.2021.770381. eCollection 2021. Front Med (Lausanne). 2021. PMID: 34901085 Free PMC article.
Reinforcement of cell-mediated immunity driven by tumor-associated Epstein-Barr virus (EBV)-specific T cells during targeted B-cell therapy with rituximab.
Tischer-Zimmermann S, Bonifacius A, Santamorena MM, Mausberg P, Stoll S, Döring M, Kalinke U, Blasczyk R, Maecker-Kolhoff B, Eiz-Vesper B. Tischer-Zimmermann S, et al. Front Immunol. 2023 Mar 24;14:878953. doi: 10.3389/fimmu.2023.878953. eCollection 2023. Front Immunol. 2023. PMID: 37033971 Free PMC article.
Modulation of TAP-dependent antigen compartmentalization during human monocyte-to-DC differentiation.
Döring M, Blees H, Koller N, Tischer-Zimmermann S, Müsken M, Henrich F, Becker J, Grabski E, Wang J, Janssen H, Zuschratter W, Neefjes J, Klawonn F, Eiz-Vesper B, Tampé R, Kalinke U. Döring M, et al. Among authors: tischer zimmermann s. Blood Adv. 2019 Mar 26;3(6):839-850. doi: 10.1182/bloodadvances.2018027268. Blood Adv. 2019. PMID: 30867143 Free PMC article.
COVID-19 immune signatures reveal stable antiviral T cell function despite declining humoral responses.
Bonifacius A, Tischer-Zimmermann S, Dragon AC, Gussarow D, Vogel A, Krettek U, Gödecke N, Yilmaz M, Kraft ARM, Hoeper MM, Pink I, Schmidt JJ, Li Y, Welte T, Maecker-Kolhoff B, Martens J, Berger MM, Lobenwein C, Stankov MV, Cornberg M, David S, Behrens GMN, Witzke O, Blasczyk R, Eiz-Vesper B. Bonifacius A, et al. Among authors: tischer zimmermann s. Immunity. 2021 Feb 9;54(2):340-354.e6. doi: 10.1016/j.immuni.2021.01.008. Immunity. 2021. PMID: 33567252 Free PMC article.
Antiviral T-Cell Frequencies in a Healthy Population: Reference Values for Evaluating Antiviral Immune Cell Profiles in Immunocompromised Patients.
Schulze Lammers FC, Bonifacius A, Tischer-Zimmermann S, Goudeva L, Martens J, Lepenies B, von Karpowitz M, Einecke G, Beutel G, Skripuletz T, Blasczyk R, Beier R, Maecker-Kolhoff B, Eiz-Vesper B. Schulze Lammers FC, et al. Among authors: tischer zimmermann s. J Clin Immunol. 2022 Apr;42(3):546-558. doi: 10.1007/s10875-021-01205-1. Epub 2022 Jan 6. J Clin Immunol. 2022. PMID: 34989946 Free PMC article.
High-intensity interval training in allogeneic adoptive T-cell immunotherapy - a big HIT?
Heinemann NC, Tischer-Zimmermann S, Wittke TC, Eigendorf J, Kerling A, Framke T, Melk A, Heuft HG, Blasczyk R, Maecker-Kolhoff B, Eiz-Vesper B. Heinemann NC, et al. Among authors: tischer zimmermann s. J Transl Med. 2020 Apr 1;18(1):148. doi: 10.1186/s12967-020-02301-3. J Transl Med. 2020. PMID: 32238166 Free PMC article.
Adenoviral Penton and Hexon Proteins Are Equivalent Immunogenic Targets of Virus-Specific T Cells after Hematopoietic Stem Cell Transplantation in Children.
Wintering A, Tischer-Zimmermann S, Schultze-Florey R, Beier R, Sauer M, Blasczyk R, Heim A, Eiz-Vesper B, Maecker-Kolhoff B. Wintering A, et al. Among authors: tischer zimmermann s. Transplant Cell Ther. 2023 Jun;29(6):391.e1-391.e7. doi: 10.1016/j.jtct.2023.03.013. Epub 2023 Mar 18. Transplant Cell Ther. 2023. PMID: 36934995
Adoptive Allogeneic T-Cell Therapy Improves the Clinical Outcome of JC Virus Granule Cell Neuronopathy: A Case Report.
Grote-Levi L, Möhn N, Bonifacius A, Tischer-Zimmermann S, Schweitzer F, Mahmoudi N, Silling S, Warnke C, Maecker-Kolhoff B, Wattjes MP, Eiz-Vesper B, Höglinger GU, Skripuletz T. Grote-Levi L, et al. Among authors: tischer zimmermann s. Neurol Neuroimmunol Neuroinflamm. 2023 Jun 29;10(5):e200138. doi: 10.1212/NXI.0000000000200138. Print 2023 Sep. Neurol Neuroimmunol Neuroinflamm. 2023. PMID: 37385737 Free PMC article.
18 results